Nabiha A Bouafia, Manish Dhawan, Manish Sharma, Mona A Al Fares, Ali Bayahya, Khadija H Al-Abdulali, Batool Mohammed Abu Ali, Ali H Alhaddad, Hatem M Alhani, Abeer M AlBaadani, Abdulrahman M Alsulaiman, Mohammed Alissa, Nawal A Al Kaabi, Hayam A Alrasheed, Maha F Al-Subaie, Mohammed Abdulrahman Alshahrani, Maha Fahad Alenazy, Wadha A Alfouzan, Ali A Rabaan, Nanamika Thakur, Faryal Khamis, Ahmad A Alshehri
Journal: Journal of infection and public health 2023;16(11):1870-1883
PMID: 37839310
SARS-CoV-2, responsible for COVID-19, shares 79% and 50% of its identity with SARS-CoV-1 and MERS-CoV, respectively. It uses the same main cell attachment and entry receptor as SARS-CoV-1, which is the ACE-2 receptor. However, key residues in the receptor-binding domain of its S-protein seem to give it a stronger affinity for the receptor and a better ability to hide from the host immune system. Like SARS-CoV-1 and MERS-CoV, cytokine storms in critically ill COVID-19 patients cause ARDS, neurological pathology, multiorgan failure, and increased death. Though many issues remain, the global research effort and lessons from SARS-CoV-1 and MERS-CoV are hopeful. The emergence of novel SARS-CoV-2 variants and subvariants raised serious concerns among the scientific community amid the emergence of other viral diseases like monkeypox and Marburg virus, which are major concerns for healthcare settings worldwide. Hence, an updated review on the comparative analysis of various coronaviruses (CoVs) has been developed, which highlights the evolution of CoVs and their repercussions.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Full Text Sources:
Medical:
Miscellaneous:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.